China Medical Technologies Invests $345 Million In HPV Genotyping Chip
This article was originally published in The Gray Sheet
Executive Summary
China Medical Technologies is acquiring a human papillomavirus genotyping assay which it expects will generate up to $26.5 million in sales next year
You may also be interested in...
Far East Financials: Two Large Chinese Device Firms Report Mixed Growth
China Medical's molecular diagnostic system sales were up 10% in the first quarter to $15.9 million, driven by progress with its fluorescent in situ hybridization probe business, the Beijing company reported Aug. 16
Far East Financials: Two Large Chinese Device Firms Report Mixed Growth
China Medical's molecular diagnostic system sales were up 10% in the first quarter to $15.9 million, driven by progress with its fluorescent in situ hybridization probe business, the Beijing company reported Aug. 16
China Medical Reels In FISH Test Revenues; Q3 Sales Up 51%
Not everyone is losing money in the global economic slump. China Medical Technologies, a Beijing in vitro diagnostics company, generated sales of $33 million in the 2008 third quarter (ended Dec. 31), a 51% increase over the prior-year period, according to unaudited results released March 2